Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 5, 1999, Pages 762-771

  Bosch, R F ^a,b   Milek, I V ^a   Popovic, K ^a   Mermi, J ^a   Mewis, C ^a   Kuhlkamp V ^a   Seipel, L ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Acetylcholine activated current; Atrial repolarization; Cardiac pharmacology; Class III antiarrhythmics; Inward rectifier current; Sustained outward current; Transient outward current

Indexed keywords

ACETYLCHOLINE; AMBASILIDE; ANTIARRHYTHMIC AGENT; LU 47710; UNCLASSIFIED DRUG;

ADULT; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART ATRIUM; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HUMAN; HUMAN TISSUE; MALE; POTASSIUM CURRENT; PRIORITY JOURNAL;

ACTION POTENTIALS; AMINOBENZOIC ACIDS; ANTI-ARRHYTHMIA AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS;

EID: 0032916312     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199905000-00013     Document Type: Article

References (41)

1. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-11.
2. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.
3. + current by dofetilide. Circ Res 1993;72:75-83.
4. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992;262:809-17.
5. Wettwer E, Grundke M, Ravens U. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes. Cardiovasc Res 1992;26:1145-52.
6. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction: the SWORD investigators: survival with oral d-sotalol. Lancet 1996;348:7-12.
7. Takanaka C, Sarma JS, Singh BN. Electrophysiologic effects of ambasilide (LU 47110): a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle. J Cardiovasc Pharmacol 1992;19:290-8.
8. Zhang ZH, Follmer CH, Sarma JSM, Chen F, Singh BN. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current. J Pharmacol Exp Ther 1992;263:40-8.
9. + channel blockers and muscarinic receptor stimulation. J Pharmacol Exp Ther 1995;273:1095-104.
10. Wang J, Feng J, Nattel S. Class III antiarrhythmic drug action in experimental atrial fibrillation: differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 1994;90:2032-40.
11. Koidl B, Flaschberger P, Schaffer P, et al. Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol 1996; 353:226-32.
12. Feng J, Wang Z, Li GR, Nattel S. Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 1997; 281:384-92.
13. + current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res 1998;38:441-50.
14. Gjini V, Korth M, Schreieck J, Weyerbrock S, Schomig A, Schmitt C. Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies. J Cardiovasc Pharmacol 1996;28:314-20.
15. Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use dependence. Circulation 1990;81:686-90.
16. Nattel S, Zeng FD. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers. J Pharmacol Exp Ther 1984;229:283-91.
17. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-44.
18. Roden DM. Current status of class III antiarrhythmic drug therapy. Am J Cardiol 1993;72:44B-9B.
19. Schmitt C, Karch M, Schreieck S, Weyerbrock S, Plewan A, Schneider MAE. Effects of the new class III antiarrhythmic agent ambasilide on monophasic and transmembrane action potential in human ventricular myocardium [Abstract]. Eur Heart J 1996;17:389.
20. Schreieck J, Korth M, Meisner H, Weyerbrock S, Schmitt C, Schömig A. Rate-independent prolongation of transmembrane action potential by ambasilide in failing human myocardium [Abstract]. J Am Coll Cardiol 1996;374A:1019.
21. Koller B, Sedlmayr V, Zrennner B, et al. Use-dependent effects of ambasilide on repolarization and refractoriness in the isolated rabbit heart [Abstract]. Eur Heart J 1995;16:462.
22. Stramba-Badiale M, Pessano P, Kirchengast M, Schwartz PJ. Effects of the potassium channel blocking agent ambasilide on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation. Am Heart J 1995;129:549-56.
23. Cerbai E, Klockner U, Isenberg G. Ca-antagonistic effects of adenosine in guinea pig atrial cells. Am J Physiol 1988;255:H872-8.
24. Visentin S, Wu SN, Belardinelli L. Adenosine-induced changes in atrial action potential: contribution of Ca- and K-currents. Am J Physiol 1990;258:H1070-8.
25. Allessie R, Nusynowitz M, Abildskov JA, Moe GK. Non-uniform distribution of vagal effects on atrial refractory period. Am J Physiol 1958;194:406-10.
26. Allessie MA, Lammers WJ, Bonke IM, Hollen J. Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation 1984;70:123-35.
27. Coumel P. Role of the autonomie nervous system in paroxysmal atrial fibrillation. Clin Cardiol 1990;13:209-12.
28. Waxman MB, Cameron DA, Wald RW. Interactions between the autonomie nervous system and supraventricular tachycardia in humans. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. 2nd ed. Philadelphia: WB Saunders, 1995:699-722.
29. Wang Z, Page P, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71: 271-87.
30. + channels in mammalian ventricular myocytes. Am J Physiol 1994; 266:H1812-21.
31. Bosch RF, Li GR, Gaspo R, Nattel S. Ionic mechanisms of electrophysiologic effects of chronic amiodarone therapy and hypothyroidism: does amiodarone act via cardiac hypothyroidism? [Abstract]. Circulation 1996;94:I-161.
32. Varró A, Virág L, Papp JG. Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes. Br J Pharmacol 1996;117: 1181-6.
33. Balser JR, Bennett PB, Hondeghem LM, Roden DM. Suppression of time-dependent outward current in guinea pig ventricular myocytes: actions of quinidine and amiodarone. Circ Res 1991;69:519-29.
34. + channel activities of cultured rat cardiomyocytes. J Mol Cell Cardiol 1997;29:617-27.
35. Kamiya K, Cheng J, Kodama I, Toyama J. Acute and chronic effects of amiodarone on action potential and ionic currents in single rabbit ventricular myocytes. In: Toyama J, Hiraoka M, Kodama I, eds. Recent progress in electropharmacology of the heart. Boca Raton, FL: CRS Press, 1995:139-49.
36. Sato R, Koumi SI, Singer DH, et al. Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells. J Pharmacol Exp Ther 1994;269:1213-9.
37. Watanabe Y, Hara Y, Tamagawa M, Nakaya H. Inhibitory effect of amiodarone on the muscarinic acetylcholine-operated potassium current in guinea pig atrial cells. J Pharmacol Exp Ther 1996;279: 617-24.
38. Sager PT, Follmer C, Uppal P, Pruitt C, Godfrey R. The effects of β-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Circulation 1994;90:1811-9.
39. Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 1994;28:1540-6.
40. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 1993;73:276-85.
41. Yue L, Feng J, Li GR, Nattel S. Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol 1996;270:H2157-68.